National General Holdings Corp. Announces Dividends on Common and Preferred Stock
Feb 26, 2018 18:00 pm UTC| Business
NEW YORK, Feb. 26, 2018 -- National General Holdings Corp. (NASDAQ:NGHC) today announced that its Board of Directors approved quarterly dividends on the company's common and preferred stock as follows: A cash dividend...
Feb 26, 2018 18:00 pm UTC| Business
DRESDEN, Germany, Feb. 26, 2018 -- SILTECTRA GmbH, a leader in advanced wafering technology solutions and services, today reports that it has validated a breakthrough capability for its COLD SPLIT technology. COLD SPLIT...
Blaze Fast-Fire’d Pizza Announces Grand Opening of Second Kansas location
Feb 26, 2018 17:59 pm UTC| Business
LOS ANGELES, Feb. 26, 2018 -- Blaze Fast-Fire’d Pizza, the fast-casual artisanal pizza concept known for its chef-driven menu and casually hip restaurants, announced today that it will open its second Kansas location,...
NEW REPORT: Worldwide spending on legal cannabis will reach $57 billion by 2027
Feb 26, 2018 17:59 pm UTC| Business
Oakland, CA, Feb. 26, 2018 -- Worldwide consumer spending on legal cannabis is projected to reach $57 billion by 2027, according to the “The Road Map to a $57 Billion Worldwide Market” report released today by Arcview...
New Research Shows Blockchain Speeds Product Development for Mobile Operators
Feb 26, 2018 17:56 pm UTC| Business
NEW YORK, Feb. 26, 2018 -- The Digital Supply Chain Institute (DSCI), in partnership with Aricent and the Bitfury Group, today announced the results of pilot projects that demonstrate blockchain technology can deliver...
Azul Systems Takes Java on the Road to London, Nuremberg, and Siberia
Feb 26, 2018 17:50 pm UTC| Business
Sunnyvale, Calif. USA, Feb. 26, 2018 -- Azul Systems (Azul), the award-winning leader in Java runtime solutions, today announced that it would be supporting a series of industry events and technical presentations...
OncBioMune Provides Updates on two Phase 2 Clinical Trials of ProscaVax for Prostate Cancer
Feb 26, 2018 17:47 pm UTC| Business
BATON ROUGE, La., Feb. 26, 2018 -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary immunotherapy...